Sernova Biotherapeutics Inc. (T.SVA)

Last Closing Price: --

EBIT (Annual)

EBIT: Income before interest and taxes.

Sernova Biotherapeutics Inc. (T.SVA) had EBIT of -10.72M for the most recently reported fiscal year, ending 2025-10-31.

Figures for fiscal year ending 2025-10-31
Income Statement Financials
--
-11.24M
--
--
--
-10.72M
--
-11.23M
-11.23M
-11.24M
-11.24M
-11.24M
-11.24M
EBIT
-10.72M
-10.48M
328.29M
328.29M
-0.04
-0.04
Balance Sheet Financials
--
--
--
0.55M
--
--
--
18.44M
-17.90M
-17.90M
-17.90M
332.86M
Cash Flow Statement Financials
-7.79M
0.02M
3.67M
4.29M
0.19M
-4.10M
1.64M
--
--
Fundamental Metrics & Ratios
0.02
--
--
-0.04
-0.19
--
--
--
--
--
--
-7.77M
--
--
--
--
--
--
--
62.78%
62.78%
-2060.03%
65.51%
-0.08
-0.02
-0.02